Source: Annual Congress 2013 –Early detection of lung cancer



Rating:

Share or cite this content

Citations should be made in the following way:
L. Montuenga (Pamplona, Spain). Non-invasive biomarkers for the evaluation of a patient at risk for lung cancer. Annual Congress 2013 –Early detection of lung cancer

Member's Comments

No comment yet.

Related content which might interest you: Issues other than tissue: non-invasive biomarkers of early stage lung cancer Source: Virtual Congress 2020 – Will the pulmonologist still play a role in the management of screen-detected pulmonary nodules? Year: 2020 The evaluation of lung cancer patients Source: Eur Respir J 2005; 26: Suppl. 49, 323s Year: 2005 Comparision of two preoperative risk assessment algorithms in lung cancer surgery. Source: International Congress 2017 – Evaluating lung function, dyspnoea and related respiratory diseases Year: 2017 Combining pulmonary and cardiac computed tomography biomarkers for disease-specific risk modelling in lung cancer screening Source: Eur Respir J, 58 (3) 2003386; 10.1183/13993003.03386-2020 Year: 2021 Evaluation of cancer-associated thrombosis risk in patients with lung adenocarcinoma using the COMPASS-CAT risk assessment model Source: Virtual Congress 2021 – COVID-19 and management of lung cancer Year: 2021 Lung function testing for the preoperative evaluation of patients with lung cancer Source: Annual Congress 2003 - Lung function testing for preoperative evaluation in lung cancer patients Year: 2003 Noninvasive assessment in the evaluation of occupational lung diseases Source: Annual Congress 2009 - MP8 - Noninvasive assessment in the evaluation of occupational lung diseases Year: 2009 An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer Source: Annual Congress 2006 - MP11 - An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer Year: 2006 Exercise testing in the prognostic evaluation of patients with lung and heart diseases Source: Eur Respir Monogr 2018; 80: 222-234 Year: 2018 Time in lung cancer diagnosis and its prognostic implication Source: International Congress 2018 – Lung cancer: risk factors, supportive measures and quality improvement Year: 2018 Lung function predicts lung cancer risk in smokers: a tool for targeting screening programmes Source: Eur Respir J 2010; 35: 146-151 Year: 2010 Prevalence and characterization of interstitial lung disease in a lung cancer screening program Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis Year: 2019 Possible predictors of the bronchodilation test response within lung function assessment of patients with operable lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 326s Year: 2005 Possibility of noninvasive differential diagnostics of lung tuberculosis and lung cancer in oncologic hospital Source: Eur Respir J 2003; 22: Suppl. 45, 160s Year: 2003 Lung function assessment in octogenarians with lung cancer diagnosis Source: International Congress 2017 – Thoracic surgery Year: 2017 Evaluation of cardiovascular risk in a lung cancer screening cohort: what value does it bring? Source: Breathe, 16 (4) 200204; 10.1183/20734735.0204-2020 Year: 2020 Nutritional assessment for patients with lung cancer Source: Virtual Congress 2020 – Management issues in thoracic oncology Year: 2020